513 material Form 8-K filings that 427 companies we cover made with the SEC in November 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Arrowhead Pharmaceuticals reported a fiscal 2024 net loss attributable to the company of $599.5 million, or $5.00 per diluted share, for the year ended September 30, 2024, compared with a loss of $205.3 million, or $1.92 per share, a year earlier. Revenue fell to $3.6 million from $240.7 million, while research and development expense rose to $505.9 million from $353.2 million. The company said its recent Sarepta licensing deal and Sixth Street credit facility, both announced in the filing period, extend its cash runway into 2028.
Revenue was $3.6 million in fiscal 2024 versus $240.7 million in fiscal 2023.
Diluted net loss per share was $5.00 versus $1.92 a year earlier.
Research and development expense was $505.9 million versus $353.2 million.
Sarepta agreement provides $825 million upon closing, including a $325 million equity investment; Sixth Street facility is $500 million, with $400 million funded at close.
Buckle reported third-quarter fiscal 2024 results for the quarter ended November 2, 2024. Net sales fell 3.2% to $293.6 million and net income fell to $44.2 million, or $0.88 per diluted share, from $51.8 million, or $1.04 per diluted share, a year earlier. Both headline measures declined, which weighs on shareholders, though online sales rose 1.1%.
Net sales for the quarter decreased 3.2% to $293.6 million from $303.5 million; comparable store net sales decreased 0.7%.
Online sales rose 1.1% to $46.6 million for the quarter.
Quarterly net income was $44.2 million, or $0.89 per share ($0.88 diluted), versus $51.8 million, or $1.05 per share ($1.04 diluted), a year earlier.
Year-to-date net income was $118.3 million, or $2.37 per share ($2.35 diluted), versus $140.3 million for the prior-year period.
ADM reported third quarter 2024 GAAP net earnings attributable to the company of $18 million, or $0.04 per diluted share, compared with $821 million, or $1.52 per share, a year earlier. The results include a $461 million non-cash impairment charge on its Wilmar equity investment, and adjusted EPS was $1.09. ADM also filed restated financial statements for fiscal 2023 and the first two quarters of 2024, which it says did not affect consolidated results, and affirmed its full-year 2024 adjusted EPS range of $4.50 to $5.00.
Revenues were $19.9 billion, down from $21.7 billion in the prior-year quarter.
Total segment operating profit was $1,037 million, down 28% from $1,446 million.
Full-year 2024 adjusted EPS guidance of $4.50 to $5.00 was affirmed, not changed.
Fourth quarter AS&O segment operating profit is expected to be lower than a year earlier; Nutrition is expected to be higher than a year earlier but lower than the third quarter.
Kulicke and Soffa reported fiscal fourth-quarter 2024 net revenue of $181.3 million, down 10.4% from a year earlier, with GAAP net income of $12.1 million, or $0.22 per diluted share, down 46.3%. For the first quarter of fiscal 2025, the company expects net revenue of about $165.0 million, plus or minus $10 million, and non-GAAP diluted EPS of about $0.28, which includes a claim or proceeds from the cessation of business related to Project W.
Q4 fiscal 2024 net revenue $181.3 million, down 10.4% year over year; GAAP diluted EPS $0.22 versus $0.41 a year earlier
Non-GAAP diluted EPS $0.34, down 33.3% year over year; fiscal 2024 net loss of $69.0 million, or $(1.24) per share, including $44.5 million in impairment charges
Q1 fiscal 2025 outlook: net revenue about $165.0 million, +/- $10 million; GAAP diluted EPS about $1.45, including a $75.0 million claim or proceeds item; non-GAAP diluted EPS about $0.28
Company repurchased 3.2 million shares for $151.0 million in fiscal 2024; cash and short-term investments were $577.1 million as of September 28, 2024
ePlus reported fiscal second-quarter results for the three months ended September 30, 2024, with net sales down 12.3% and diluted earnings per share down to $1.17 from $1.22. Consolidated gross profit rose 2.5%, helped by services and financing revenue, and the company now expects fiscal 2025 net sales similar to fiscal 2024 and adjusted EBITDA of $195 million to $205 million.
Q2 net sales fell 12.3% to $515.2 million; product sales fell 22.2% to $389.6 million, while services revenue rose 46.0% to $103.7 million
Consolidated gross profit rose 2.5% to $148.0 million, and gross margin was 28.7%, compared with 24.6% a year earlier
Net earnings fell 4.1% to $31.3 million; adjusted EBITDA fell 2.7% to $52.1 million
Fiscal 2025 guidance: net sales now expected to be similar to fiscal 2024; adjusted EBITDA now expected at $195 million to $205 million
Sunstone Hotel Investors reported third-quarter 2024 net income of $3.2 million, down from $15.6 million a year earlier, and lowered its full-year 2024 net income and Adjusted FFO per share guidance, citing labor activity at the Hilton San Diego Bayfront, Florida weather and a slower recovery in Maui. The company also entered a $100 million unsecured delayed draw term loan that it expects to draw in early December to repay a $72.1 million loan secured by the JW Marriott New Orleans, which it says would leave all its hotels unencumbered and no debt maturities before 2026.
Q3 2024 net income was $3.2 million versus $15.6 million in Q3 2023; Adjusted EBITDAre fell 15.9% to $53.6 million
Adjusted FFO per diluted share was $0.18 versus $0.23, down 21.7%; comparable RevPAR fell 1.3% to $207.56
Full-year 2024 net income guidance is now $31 million to $41 million, down from $43 million to $53 million; Adjusted FFO per share guidance is $0.75 to $0.80, down from $0.79 to $0.84
The $100 million term loan matures November 7, 2025, with two six-month extension options; the company repurchased 2,688,582 shares year to date through November 11, 2024
First Advantage reported third-quarter 2024 revenue of $199.1 million, down 0.6% from a year earlier, and a net loss of $8.9 million versus net income of $10.8 million in the prior-year quarter. The company closed its Sterling acquisition on October 31, 2024, and kept its standalone full-year 2024 guidance while issuing combined-company guidance that includes Sterling, which shareholders will need to weigh against the lower quarterly results.
Q3 2024 revenue was $199.1 million, versus $200.4 million in Q3 2023; adjusted EBITDA was $64.0 million, versus $64.8 million.
GAAP diluted net loss per share was $(0.06), versus diluted net income of $0.07 per share a year earlier; adjusted diluted EPS was $0.26, versus $0.28.
The net loss includes $13.2 million of expenses related to the Sterling acquisition.
Standalone 2024 revenue guidance of $750 million to $800 million was maintained; combined-company revenue guidance is $858 million to $918 million.
NW Natural Holdings reported a third-quarter 2024 net loss of $27.2 million ($0.71 per share), wider than the $23.7 million loss a year earlier, on operating revenues of $136.9 million, down 3%. Nine-month net income fell 31% to $33.9 million ($0.88 per share), which the company attributed mainly to regulatory lag, and it reaffirmed its 2024 GAAP EPS guidance of $1.94 to $2.14 while raising its dividend.
Q3 2024 net loss of $27.2 million ($0.71 per share) vs. a net loss of $23.7 million ($0.65 per share) in Q3 2023
Nine-month 2024 net income of $33.9 million ($0.88 per share) vs. $49.2 million ($1.37 per share) in 2023
2024 GAAP EPS guidance of $1.94 to $2.14 reaffirmed; non-GAAP Adjusted guidance of $2.20 to $2.40
Quarterly dividend of 49 cents per share, annual indicated rate $1.96, payable Nov. 15, 2024
Metallus reported third-quarter 2024 net sales of $227.2 million and a net loss of $5.9 million, or $0.13 per diluted share, compared with net income of $24.8 million, or $0.51 per diluted share, a year earlier. The company expects adjusted EBITDA to increase modestly from the third quarter in the fourth quarter of 2024, and it also posted an updated investor presentation that includes third-quarter results.
Net sales fell 36% from $354.2 million in the third quarter of 2023 and 23% from $294.7 million in the second quarter of 2024.
Adjusted EBITDA was $6.1 million, compared with $46.8 million in the third quarter of 2023 and $19.9 million in the second quarter of 2024.
Ship tons were 119,900, down 32% from the prior-year third quarter, on lower shipments across all end markets.
Cash and cash equivalents were $254.6 million as of September 30, 2024, and total liquidity was $496.8 million.
AMN Healthcare reported third quarter 2024 revenue of $687.5 million, down 19% from a year earlier, with GAAP diluted EPS of $0.18 versus $1.39 and adjusted diluted EPS of $0.61 versus $1.97. The company guided fourth quarter revenue to $685 million to $705 million, 14% to 16% below the prior year, and separately amended its credit agreement to allow a higher maximum net leverage ratio through December 31, 2025.
Q3 2024 revenue was $687.5 million, down 19% from $853.5 million in Q3 2023; net income was $7.0 million versus $53.2 million
Fourth quarter 2024 guidance: revenue of $685 million to $705 million and operating margin of 1.8% to 2.5%
Fourth Amendment dated November 5, 2024 raises the maximum Consolidated Net Leverage Ratio to 4.50 to 1.00 for December 31, 2024 through December 31, 2025, reverting to 4.00 to 1.00 afterward
Net leverage ratio was 2.8 to 1.0 at September 30, 2024, and the company reduced debt by $60 million in the quarter
Adeia reported third-quarter 2024 revenue of $86.1 million, down from $101.4 million a year earlier, and GAAP diluted EPS of $0.17, down from $0.21. It narrowed its full-year 2024 revenue outlook to $370 million-$400 million from $380 million-$420 million and lowered its GAAP net income outlook, which weighs on shareholders even though the board raised its share repurchase authorization to $200.0 million.
Q3 2024 revenue was $86.1 million, versus $101.4 million in Q3 2023 and $87.4 million in Q2 2024.
Q3 2024 GAAP diluted EPS was $0.17 (Q3 2023: $0.21); non-GAAP diluted EPS was $0.27 (Q3 2023: $0.38).
Full-year 2024 GAAP net income outlook was lowered to $65.9 million-$69.3 million from $71.4 million-$75.6 million.
The board raised the share repurchase authorization to $200.0 million in October, and declared a $0.05 per share dividend payable December 18, 2024.
International Bancshares reported net income of $294.1 million, or $4.72 per diluted share, for the nine months ended September 30, 2024, down from $305.4 million, or $4.91 per diluted share, a year earlier. Third-quarter net income fell to $99.8 million, or $1.60 per diluted share, from $103.3 million, or $1.66, in the same period of 2023. The company cited higher rates paid on deposits and increased non-interest expenses, including inflation-driven costs and higher salary and compensation costs, as factors weighing on results.
Nine-month net income was $294.1 million, down 3.7% from $305.4 million; diluted EPS was $4.72, down 3.9% from $4.91.
Three-month net income was $99.8 million, down 3.4% from $103.3 million; diluted EPS was $1.60 versus $1.66.
Total assets were $15.9 billion at September 30, 2024, compared with $15.1 billion at December 31, 2023.
Net interest income was pressured by higher interest expense, primarily from increased rates paid on deposits.
Medical Properties Trust reported a third quarter 2024 net loss attributable to common stockholders of $801 million, or $1.34 per share, versus net income of $117 million, or $0.19 per share, a year earlier. The loss reflects about $608 million of impairment charges, largely tied to Steward hospitals, while normalized funds from operations (NFFO) fell to $94 million, or $0.16 per share, from $226 million, or $0.38 per share.
Q3 2024 net loss of $801 million ($1.34 per share) vs. net income of $117 million ($0.19 per share) in Q3 2023
NFFO of $94 million ($0.16 per share) vs. $226 million ($0.38 per share) a year earlier
$425 million impairment of Steward working capital loans and $134 million reduction in the fair value of the PHP Holdings investment
Sold 18 freestanding emergency department facilities and one general acute hospital in Arizona and Colorado for about $246 million
Halliburton reported third-quarter 2024 net income of $571 million, or $0.65 per diluted share, down from $709 million, or $0.80, in the second quarter. Revenue fell to $5.7 billion from $5.8 billion, and results included a $116 million pre-tax charge tied to severance, an asset impairment, a cybersecurity incident and other items. Management said full-year expectations for free cash flow and cash return to shareholders are unchanged and expects both to accelerate in the fourth quarter.
Revenue was $5.7 billion, compared with $5.8 billion in the second quarter of 2024.
Operating income was $871 million, versus $1.0 billion in the second quarter; adjusted operating income was $987 million.
Adjusted net income was $641 million, or $0.73 per diluted share, excluding the $116 million pre-tax charge and tax adjustments.
Management cited a $0.02 per share impact to adjusted earnings from lost or delayed revenue due to the August cybersecurity event and Gulf of Mexico storms.
Rockwell Automation reported fiscal fourth-quarter 2024 sales of $2,036 million, down 21% from a year earlier, and diluted EPS of $2.09, down 20%. Full-year fiscal 2024 sales were $8,264 million, down 9%, and diluted EPS was $8.28, down 31%. The company also issued fiscal 2025 guidance of reported sales growth between a 4% decline and 2% growth, with the CEO saying fiscal first-quarter sales are expected to be down from fourth-quarter levels.
Q4 fiscal 2024 sales $2,036 million vs. $2,563 million a year earlier; adjusted EPS $2.47, down 32%
Full-year fiscal 2024 sales $8,264 million, down 9%; diluted EPS $8.28 vs. $11.95 in fiscal 2023
Fiscal 2025 guidance: reported sales growth of (4)% to 2%; diluted EPS $7.65 to $8.85; adjusted EPS $8.60 to $9.80
Total ARR grew 16% year over year; the company repurchased $594 million of stock in fiscal 2024
Murphy Oil reported third quarter 2024 net income attributable to Murphy of $139 million, or $0.93 per diluted share, down from $255 million, or $1.63, a year earlier. Revenue from production fell to $753 million from $946 million, and adjusted net income was $111 million, or $0.74 per diluted share. The company also announced that Eric M. Hambly will succeed Roger W. Jenkins as chief executive effective January 1, 2025.
Net income attributable to Murphy was $139 million, or $0.93 per diluted share, versus $255 million, or $1.63, in Q3 2023.
Revenue from production was $753 million, compared with $946 million in Q3 2023.
Murphy repurchased $194 million of stock in Q3 and has $650 million remaining under its authorization.
Eric M. Hambly will become president and CEO on January 1, 2025, succeeding Roger W. Jenkins.
Ellington Financial reported third-quarter 2024 net income attributable to common stockholders of $16.2 million, or $0.19 per share, down from $52.3 million, or $0.62 per share, in the second quarter. Adjusted Distributable Earnings of $34.5 million, or $0.40 per share, covered its dividends, while the company's leverage rose as its credit loan portfolio grew 19%.
Net income attributable to common stockholders was $16.2 million, or $0.19 per share, versus $52.3 million, or $0.62 per share, in the quarter ended June 30, 2024.
Adjusted Distributable Earnings were $34.5 million, or $0.40 per share.
Book value per common share was $13.66 as of September 30, 2024, after dividends of $0.39 per share for the quarter.
Recourse debt-to-equity ratio rose to 1.8:1 from 1.6:1, and the company plans to redeem its Series E Preferred Stock on December 13, 2024.
Axcelis reported third-quarter 2024 revenue of $256.6 million and diluted earnings per share of $1.49, down from $1.99 a year earlier and $1.55 in the second quarter. The company guided fourth-quarter revenue to about $245 million and EPS to about $1.25, both below third-quarter results, and disclosed that it found an error that overstated historical backlog from 2019 through the second quarter of 2024.
Q3 2024 revenue of $256.6 million, roughly flat with $256.5 million in Q2 2024 and down from $292.3 million in Q3 2023
Q3 net income of $48.6 million, or $1.49 per diluted share, versus $65.9 million, or $1.99 per diluted share, in Q3 2023
Fourth-quarter 2024 outlook: revenue of approximately $245 million and EPS of approximately $1.25
Corrected backlog as of June 30, 2024 was $879 million, versus $994 million previously reported; backlog as of September 30, 2024 was $758 million
Black Hills Corp. reported third-quarter 2024 net income available for common stock of $24.4 million, down from $45.4 million a year earlier, and diluted EPS of $0.35 versus $0.67. Revenue was $401.6 million compared with $407.1 million, and the company reaffirmed its 2024 EPS guidance of $3.80 to $4.00 per share, which it says it is on track to achieve.
Q3 2024 diluted EPS was $0.35, versus $0.67 in Q3 2023; net income available for common stock was $24.4 million versus $45.4 million.
Q3 2024 revenue was $401.6 million, versus $407.1 million; nine-month diluted EPS was $2.52, versus $2.74.
2024 EPS guidance of $3.80 to $4.00 was reaffirmed, with the company citing higher operating expenses, unplanned generation outages and higher interest expense as pressures on earnings.
Black Hills completed its planned 2024 equity issuance, raising $182 million year to date, and ended the quarter at its 55% debt long-term capitalization target.
Corsair reported third-quarter 2024 net revenue of $304.2 million, down 16.2% from $363.2 million a year earlier, and a net loss attributable to common shareholders of $58.4 million, or $0.56 per diluted share, including a $32.5 million non-cash valuation allowance charge on deferred tax assets. The company lowered its full-year 2024 adjusted EBITDA outlook to $40 million to $55 million from $60 million to $75 million, while reiterating its revenue expectation of $1.25 billion to $1.35 billion.
Net revenue was $304.2 million vs. $363.2 million a year earlier; Gaming Components and Systems fell to $202.2 million from $272.8 million, while Gamer and Creator Peripherals rose to $102.0 million from $90.4 million.
Adjusted net loss was $30.3 million, or $0.29 per diluted share, vs. adjusted net income of $13.4 million, or $0.13 per diluted share, in Q3 2023.
Adjusted EBITDA was $4.8 million vs. $23.0 million in Q3 2023.
Adjusted operating income outlook for 2024 is $28 million to $43 million, down from $48 million to $63 million; adjusted EBITDA outlook is $40 million to $55 million, down from $60 million to $75 million.
Xencor reported third-quarter 2024 results on November 6, 2024. Revenue fell to $10.7 million from $59.2 million a year earlier, and the net loss attributable to Xencor widened to $45.1 million, or $(0.71) per share, from $24.3 million, or $(0.40) per share. The company expects to end 2024 with between $690 million and $710 million in cash, cash equivalents and marketable debt securities.
Revenue was $10.7 million for the quarter ended September 30, 2024, versus $59.2 million a year earlier, mainly non-cash royalty revenue from Alexion and Incyte.
R&D expenses were $58.2 million, down from $64.9 million, while G&A expenses rose to $14.8 million from $12.5 million.
Other income, net was $16.0 million, compared with other expense, net of $6.0 million a year earlier.
Cash, cash equivalents and marketable debt securities were $754.3 million at September 30, 2024; year-end 2024 guidance is $690 million to $710 million.
Sempra reported third-quarter 2024 GAAP earnings of $638 million, or $1.00 per diluted share, down from $721 million, or $1.14, a year earlier, and adjusted earnings of $566 million, or $0.89 per share, versus $685 million, or $1.08. Third-quarter revenue fell to $2.776 billion from $3.334 billion, and the company affirmed its 2024 adjusted EPS guidance of $4.60 to $4.90 while raising its GAAP EPS guidance range to $4.86 to $5.16 and announcing a $3 billion at-the-market equity offering program.
Q3 2024 GAAP earnings of $638 million ($1.00 per diluted share) vs. $721 million ($1.14) in Q3 2023
Q3 2024 adjusted EPS of $0.89 vs. $1.08 a year earlier; revenue of $2.776 billion vs. $3.334 billion
Full-year 2024 GAAP EPS guidance updated to $4.86 to $5.16; adjusted EPS guidance of $4.60 to $4.90 affirmed; 2025 EPS guidance of $4.90 to $5.25 affirmed
$3 billion at-the-market equity offering program put in place; Oncor expects a 40-50% increase to its five-year capital plan of $24 billion, with an update in February 2025
Vishay reported fiscal third quarter 2024 results on November 6, 2024. Revenue fell from the prior quarter and year-earlier levels, and the company posted a GAAP loss of $0.14 per share after $40.6 million in restructuring and severance costs, with adjusted EPS of $0.08. For the fourth quarter, management expects revenue of $720 million, plus or minus $20 million, which is below the third-quarter level.
Q3 2024 revenue was $735.4 million, down from $741.2 million in Q2 2024 and $853.7 million in Q3 2023.
GAAP loss per share was $0.14, compared with GAAP earnings of $0.47 per share a year earlier; adjusted EPS was $0.08 versus $0.60.
Restructuring and severance costs totaled $40.6 million in the quarter, and gross margin fell to 20.5% from 27.8% a year earlier.
Q4 2024 outlook calls for revenue of $720 million, plus or minus $20 million, and gross margin of 20.0%, plus or minus 50 basis points.
Innospec reported third-quarter 2024 results with revenue down 4% to $443.4 million and GAAP diluted EPS of $1.33, versus $1.57 a year earlier. The board also declared a semi-annual dividend of $0.79 per share, raising the full-year 2024 dividend to $1.55, a 10% increase over 2023.
Total revenue $443.4 million vs $464.1 million a year earlier; net income $33.4 million vs $39.2 million
Adjusted non-GAAP EPS $1.35 vs $1.59 a year earlier; Oilfield Services operating income fell 57% to $7.1 million
Dividend of $0.79 per share payable November 26, 2024, to holders of record on November 18, 2024
Cash and cash equivalents of $303.8 million at September 30, 2024, with no debt
Marathon Petroleum reported third-quarter 2024 net income attributable to MPC of $622 million, or $1.87 per diluted share, down from $3.3 billion, or $8.28 per share, a year earlier. The decline was driven primarily by lower market crack spreads in its Refining & Marketing segment, though the board raised the quarterly dividend and approved an additional $5 billion share repurchase authorization.
Adjusted EBITDA was $2.5 billion in Q3 2024, versus $5.7 billion in Q3 2023.
Refining & Marketing margin was $14.35 per barrel, versus $26.16 per barrel a year earlier.
Quarterly dividend increased to $0.91 per share, payable December 10, 2024, to holders of record on November 20, 2024.
Company has $8.5 billion available under its share repurchase authorizations after the new $5 billion approval.
NXP reported third quarter 2024 revenue of $3.25 billion, down 5% from a year earlier but up 4% from the second quarter. GAAP diluted earnings per share were $2.79, compared with $3.01 a year earlier, and it guided fourth quarter revenue to $3.0 billion to $3.2 billion, below the third quarter level, citing broader macro weakness in Europe and the Americas.
Q3 2024 revenue $3.25 billion, down 5% year over year and up 4% from Q2 2024
GAAP diluted EPS $2.79 vs. $3.01 in Q3 2023; non-GAAP diluted EPS $3.45 vs. $3.70
Q4 2024 revenue guidance $3.0 billion to $3.2 billion; non-GAAP diluted EPS guidance $2.93 to $3.33
Q3 capital return of $564 million, including $305 million in share repurchases; board authorized an additional $2.0 billion for buybacks on August 29
Vornado Realty Trust reported a net loss attributable to common shareholders of $19,154,000, or $0.10 per diluted share, for the quarter ended September 30, 2024, compared with net income of $52,846,000, or $0.28 per diluted share, a year earlier. Revenues fell to $443,255,000 from $450,995,000, and FFO attributable to common shareholders plus assumed conversions dropped to $0.50 per diluted share from $0.62, so shareholders saw lower reported earnings and cash-flow-based performance in the quarter.
Q3 2024 net loss attributable to common shareholders: $19,154,000 ($0.10 per diluted share), versus net income of $52,846,000 ($0.28) in Q3 2023
Q3 2024 FFO attributable to common shareholders plus assumed conversions: $99,256,000 ($0.50 per diluted share), versus $119,487,000 ($0.62)
FFO, as adjusted, was $102,755,000 ($0.52 per diluted share), versus $127,241,000 ($0.66); same store NOI at share fell 8.4% year over year for the three months
Revenues for the quarter were $443,255,000, compared with $450,995,000 in the prior-year quarter
Boise Cascade reported third quarter 2024 net income of $91.0 million, or $2.33 per diluted share, on sales of $1.7 billion, compared with $143.1 million, or $3.58 per share, on $1.8 billion a year earlier. The company said lower plywood and engineered wood prices and higher conversion costs reduced Wood Products segment income, and that Building Materials Distribution segment income also declined. For shareholders, the filing also shows a $0.21 quarterly dividend and an authorization to repurchase 1.4 million more shares.
Net income of $91.0 million ($2.33 diluted per share) versus $143.1 million ($3.58) in third quarter 2023
Sales of $1.7 billion, down 7%; Wood Products segment income fell 46% to $53.9 million
Board declared a $0.21 per share quarterly dividend payable December 18, 2024, and authorized 1.4 million additional shares for repurchase on October 30, 2024
Expected capital expenditures of $220 million to $240 million in 2024 and $200 million to $220 million in 2025
Silicon Labs reported third-quarter 2024 revenue of $166 million, down from $203.8 million a year earlier, and a GAAP diluted loss of $(0.88) per share compared with diluted earnings of $0.32 a year earlier. The company guided fourth-quarter revenue to $161 million to $171 million and a GAAP diluted loss per share of $(0.75) to $(1.05), so the year-over-year decline and losses are expected to continue into the next quarter.
Q3 revenue was $166 million, versus $203.8 million in the third quarter of 2023; the company cited sequential growth in Industrial & Commercial and Home & Life revenue.
GAAP operating loss was $30 million and non-GAAP operating loss was $8 million; non-GAAP diluted loss per share was $(0.13).
Fourth-quarter 2024 outlook: revenue of $161 million to $171 million and GAAP diluted loss per share of $(0.75) to $(1.05).
Sensata reported third-quarter 2024 revenue of $982.8 million, down 1.8% from a year earlier, and a GAAP operating loss of $199.2 million that includes a $150.1 million goodwill impairment tied to Dynapower and about $141 million in restructuring and other charges. Adjusted EPS fell 5.5% to $0.86, and the company guided fourth-quarter revenue to $870 million to $900 million and adjusted EPS to $0.71 to $0.76, both below third-quarter levels.
Revenue was $982.8 million, down $18.5 million or 1.8% from $1,001.3 million in Q3 2023.
GAAP loss per share was $0.17, compared with EPS of $0.41 in Q3 2023; the result includes a $258 million tax benefit from a valuation allowance release.
Adjusted EPS was $0.86, down $0.05 or 5.5% from $0.91.
Q4 2024 guidance: revenue of $870 million to $900 million and adjusted EPS of $0.71 to $0.76, versus Q3 revenue of $982.8 million and adjusted EPS of $0.86.
Franklin Resources reported preliminary fourth-quarter fiscal 2024 results, showing a net loss of $84.7 million, or $0.19 per diluted share, compared with net income of $295.5 million, or $0.58 per share, a year earlier. The loss reflects a $389.2 million impairment of an indefinite-lived intangible asset tied to certain mutual fund contracts managed by Western Asset Management, even as operating revenues rose 11% to $2.21 billion.
Q4 net loss of $84.7 million, or $0.19 per diluted share, versus net income of $295.5 million, or $0.58 per share, a year earlier
Impairment of $389.2 million on an intangible asset related to mutual fund contracts managed by Western Asset Management
Operating revenues of $2.21 billion, up 11% from the prior-year quarter
Adjusted diluted EPS of $0.59 for the quarter, versus $0.84 a year earlier (non-GAAP)
Alpha Metallurgical Resources reported third-quarter 2024 net income of $3.8 million, or $0.29 per diluted share, down from $58.9 million, or $4.49 per share, in the second quarter and $93.8 million a year earlier. Adjusted EBITDA was $49.0 million, compared with $116.0 million in the second quarter. The company also issued 2025 operational guidance and said it has committed 3.7 million tons to domestic customers at an average of $152.51 per ton.
Net income was $3.8 million, or $0.29 per diluted share, versus $58.9 million, or $4.49 per diluted share, in the second quarter.
Met segment coal revenues were $669.8 million, down from $800.1 million in the second quarter, and net realized pricing fell to $132.76 per ton from $141.86.
Operating cash flow rose to $189.5 million, helped by a $144.5 million decrease in working capital.
For 2025, the company expects total shipments of 16.0 million to 17.4 million tons and cost of coal sales of $103.00 to $108.00 per ton.
Proto Labs reported third quarter 2024 revenue of $125.6 million, down 3.9% from $130.7 million a year earlier, with GAAP diluted earnings of $0.29 per share versus $0.31. It also gave a fourth quarter 2024 revenue outlook of $115 million to $123 million and GAAP diluted EPS of $0.10 to $0.18. For shareholders, the headline revenue and profit measures both declined year over year, and the company said it generated $24.8 million in operating cash flow in the quarter.
Q3 2024 revenue was $125.6 million, down 3.9% from $130.7 million in Q3 2023.
Q3 2024 GAAP net income was $7.2 million, or $0.29 per diluted share, versus $8.0 million, or $0.31, a year earlier.
Q3 2024 Adjusted EBITDA was $21.9 million, or 17.4% of revenue, versus $23.9 million, or 18.3%, in Q3 2023.
Q4 2024 outlook: revenue of $115 million to $123 million and GAAP diluted EPS of $0.10 to $0.18.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.